Show simple item record

dc.contributor.authorRoberts, Tara L.
dc.contributor.authorHo, Uda
dc.contributor.authorLuff, John
dc.contributor.authorLee, C. Soon
dc.contributor.authorApte, Simon H.
dc.contributor.authorMacDonald, Kelli P. A.
dc.contributor.authorRaggat, Liza J.
dc.contributor.authorPettit, Allison R.
dc.contributor.authorMorrow, Carl A.
dc.contributor.authorWaters, Michael J.
dc.contributor.authorChen, Phil
dc.contributor.authorWoods, Rick G.
dc.contributor.authorThomas, Gethin P.
dc.contributor.authorSt. Pierre, Liam
dc.contributor.authorFarah, Camile S.
dc.contributor.authorClarke, Raymond A.
dc.contributor.authorBrown, James A. L.
dc.contributor.authorLavin, Martin F.
dc.date.accessioned2018-09-20T16:22:58Z
dc.date.available2018-09-20T16:22:58Z
dc.date.issued2012-12-31
dc.identifier.citationRoberts, Tara L. Ho, Uda; Luff, John; Lee, C. Soon; Apte, Simon H.; MacDonald, Kelli P. A.; Raggat, Liza J.; Pettit, Allison R.; Morrow, Carl A.; Waters, Michael J.; Chen, Phil; Woods, Rick G.; Thomas, Gethin P.; St. Pierre, Liam; Farah, Camile S.; Clarke, Raymond A.; Brown, James A. L.; Lavin, Martin F. (2012). Smg1 haploinsufficiency predisposes to tumor formation and inflammation. Proceedings of the National Academy of Sciences 110 (4), E285-E294
dc.identifier.issn0027-8424,1091-6490
dc.identifier.urihttp://hdl.handle.net/10379/13668
dc.description.abstractSMG1 is a member of the phosphoinositide kinase-like kinase family of proteins that includes ATM, ATR, and DNA-PK, proteins with known roles in DNA damage and cellular stress responses. SMG1 has a well-characterized role in nonsense-mediated decay as well as suggested roles in the DNA damage response, resistance to oxidative stress, regulation of hypoxic responses, and apoptosis. To understand the roles of SMG1 further, we generated a Genetrap Smg1 mouse model. Smg1 homozygous KO mice were early embryonic lethal, but Smg1 heterozygous mice showed a predisposition to a range of cancers, particularly lung and hematopoietic malignancies, as well as development of chronic inflammation. These mice did not display deficiencies in known roles of SMG1, including nonsense-mediated decay. However, they showed elevated basal tissue and serum cytokine levels, indicating low-level inflammation before the development of tumors. Smg1 heterozygous mice also showed evidence of oxidative damage in tissues. These data suggest that the inflammation observed in Smg1 haploinsufficiency contributes to susceptibility to cancer and that Smg1-deficient animals represent a model of inflammation-enhanced cancer development.
dc.publisherProceedings of the National Academy of Sciences
dc.relation.ispartofProceedings of the National Academy of Sciences
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectpikk
dc.subjectimmune
dc.subjectmessenger-rna decay
dc.subjectsurveillance complex
dc.subjectmammalian-cells
dc.subjectcancer
dc.subjectkinase
dc.subjectexpression
dc.subjectchemoprevention
dc.subjectmutations
dc.subjectapoptosis
dc.subjectproteins
dc.titleSmg1 haploinsufficiency predisposes to tumor formation and inflammation
dc.typeArticle
dc.identifier.doi10.1073/pnas.1215696110
dc.local.publishedsourcehttp://www.pnas.org/content/110/4/E285.full.pdf
nui.item.downloads0


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland